Abstract
Objective Approximately 10% of pregnant individuals report a penicillin allergy, yet most are
not truly allergic. Allergy verification during pregnancy is safe and recommended;
however, many hospitals lack the infrastructure to execute testing. Our aim was to
evaluate the cost of developing and implementing a penicillin allergy referral program
for pregnant individuals at an academic institution and to compare costs of care between
patients who were referred and not referred through the program.
Study Design We conducted an economic analysis of our institution's antepartum penicillin allergy
referral program. We prospectively collected detailed resource utilization data and
conducted the analysis from the program's perspective, accounting for costs related
to program development, allergy verification, antibiotic cost, and delivery hospitalization.
Costs were compared between patients who were referred for evaluation versus patients
who were not referred using bivariate tests as well as quantile regression adjusting
for baseline differences. A sensitivity analysis was performed for allergy testing
cost. All cost estimates were inflation adjusted to 2021 U.S. dollars.
Results The startup cost of program development and educational initiatives was $19,920,
or 86 per patient. The median allergy evaluation cost was $397 (interquartile range:
$303–663). There was no significant difference in maternal (median: $13,579 vs. 13,999,
p = 0.94) or neonatal (median: $3,565 vs. 3,577, p = 0.55) delivery hospitalization cost or antibiotic cost (median: $1.57 vs. 3.87,
p = 0.10) between referred and nonreferred patients. Overall, the total cost per person
did not differ significantly between study groups (median: $18,931 vs. 18,314, p = 0.69).
Conclusion The cost of developing a penicillin allergy referral program in pregnancy was modest
and did not significantly alter short-term cost of care with potential for long-term
cost benefit. Verification of a reported penicillin allergy is an integral part of
antibiotic stewardship, and the pregnancy period should be utilized as an important
opportunity to perform this evaluation.
Key Points
-
The cost of developing and implementing an antepartum penicillin allergy referral
program is modest.
-
Program cost did not significantly alter short-term cost with a potential for long-term
cost benefit.
-
Penicillin allergy verification is an important part of antibiotic stewardship and
should be expanded.
Keywords
allergy in pregnancy - penicillin allergy - β-lactam allergy - allergy - cost - referral
program
